MiNK Therapeutics, Inc.INKTNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank80
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-2.42
↑ 70% vs avg
Percentile
P80
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-8.12
Historical baseline
PeriodValueYoY Change
2024-2.42-47.8%
2023-1.64+47.9%
2022-3.14+36.5%
2021-4.94+79.8%
2020-24.45-101.4%
2019-12.14-